Mia Mison
Psychiatric/Mental Health · Suwanee, GANPI 1548532203
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.9% of the total across 629 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,351, 2.0 times the $1,671 reported in 2021. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 629 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Alkermes, Inc.$1K
- AbbVie$1K
- Johnson & Johnson$1K
- Supernus Pharmaceuticals, Inc.$894
- Otsuka America Pharmaceutical, Inc.$805
- plus $4K from 20 others
What the payments were for
- Speaking & faculty fees$2502%
- Food & beverage$11,71798%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 92 | $1,939 |
| Alkermes, Inc. | 72 | $1,384 |
| AbbVie | 99 | $1,265 |
| Johnson & Johnson | 54 | $1,238 |
| Supernus Pharmaceuticals, Inc. | 27 | $894 |
| Otsuka America Pharmaceutical, Inc. | 36 | $805 |
| Lundbeck LLC | 35 | $647 |
| Corium, LLC | 38 | $635 |
| Tris Pharma Inc | 27 | $472 |
| Ironshore Pharmaceuticals Inc. | 25 | $411 |
| Axsome Therapeutics, Inc. | 9 | $332 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $289 |
| Noven Therapeutics, LLC | 12 | $259 |
| Vanda Pharmaceuticals Inc. | 14 | $253 |
| Teva Pharmaceuticals USA, Inc. | 17 | $249 |
| Sunovion Pharmaceuticals Inc. | 11 | $185 |
| Collegium Pharmaceutical, Inc. | 9 | $142 |
| Neurocrine Biosciences, Inc. | 6 | $136 |
| Bausch Health US, LLC | 5 | $100 |
| Neos Therapeutics, LP | 5 | $80 |
| Adlon Therapeutics L.p. | 5 | $63 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Jazz Pharmaceuticals Inc. | 3 | $42 |
| Eisai Inc. | 3 | $40 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Tempus AI, Inc | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,967 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 13 | $339 |
| Lamotrigine | 12 | $157 |
| Fluoxetine Hcl | 25 | $88 |
| Diazepam | 17 | $74 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Suwanee
- Bradley MosherSuwanee$13K
- Susan LangSuwanee$8K
- Veronica Ndegwa-GibbonsSuwanee$5K
- Candace TrippeSuwanee$5K
- Allison AndresonSuwanee$5K
- Phuong-Tuyen leSuwanee$5K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.